MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with D

Diethylstilbestrol

Diethylstilbestrol 1mg tablets

Use with caution

Stability notes for Diethylstilbestrol 1mg tablets

Protect from light.

Provenance

This compatibility recommendation is derived from Diethylstilbestrol 1mg tablets (Teva UK Ltd).

Suppliers (5) of Diethylstilbestrol 1mg tablets
Diethylstilbestrol 1mg tablets (A A H Pharmaceuticals Ltd)
Diethylstilbestrol 1mg tablets (Alliance Healthcare (Distribution) Ltd)
Diethylstilbestrol 1mg tablets (Brown & Burk UK Ltd)
Diethylstilbestrol 1mg tablets (Medihealth (Northern) Ltd)
Diethylstilbestrol 1mg tablets (Sigma Pharmaceuticals Plc)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.